Lack of proteasome active site allostery as revealed by subunit-specific inhibitors

Molecular Cell

Volumn 7, Issue 2, 2001, Pages 411-420

  Myung, Jayhyuk ^a   Kim, Kyung Bo ^a   Lindsten, Kristina ^c   Dantuma, Nico P ^c   Crews, Craig M ^a,b  

^a and Developmental Biology ^*  (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHYMOTRYPSIN; ENZYME INHIBITOR; KETONE DERIVATIVE; PEPTIDE DERIVATIVE; PROTEASOME;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME SUBUNIT; HUMAN; HUMAN CELL; HYDROLYSIS; NONHUMAN; PROTEIN DEGRADATION;

ANIMALIA;

EID: 0035099055     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(01)00188-5     Document Type: Article

References (47)

1. Proteasome inhibitors: A novel class of potent and effective antitumor agents
2. Identification of the yeast 20S proteasome catalytic centers and subunit interactions required for active-site formation
3. Eukaryotic 20S proteasome catalytic subunit propeptides prevent active site inactivation by N-terminal acetylation and promote particle assembly
4. Kinetic studies of the differential effect of detergents on the peptidase activities of the multicatalytic proteinase from rat liver
5. Covalent modification of the active site threonine of proteasomal beta subunits and the Escherichia coli homolog HslV by a new class of inhibitors
6. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes
7. Ubiquitin and the control of protein fate in the secretory and endocytic pathways
8. Components of the bovine pituitary multicatalytic proteinase complex (proteasome) cleaving bonds after hydrophobic residues
9. Purification and characterization of a protein inhibitor of the 20S proteasome (macropain)
10. Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome-dependent proteolysis in living cells
11. Degradation of oxidized insulin B chain by the multiproteinase complex macropain (proteasome)
12. Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants
13. Peptidylglutamyl-peptide hydrolase activity of the multicatalytic proteinase complex: Evidence for a new high-affinity site, analysis of cooperative kinetics, and the effect of manganese ions
14. Towards subunit specific proteasome inhibitors: Synthesis and evaluation of peptide α′,β′-epoxyketones
15. Functions of the proteasome in antigen presentation
16. Structure of 20S proteasome from yeast at 2.4 Å resolution
17. Crystal structure of epoxomicin: 20S proteasome reveals molecular basis for selectivity of α′,β′-epoxyketone proteasome inhibitors
18. The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing
19. The ubiquitin system
20. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells
21. Potent inhibitors of proteasome
22. Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: Insights into specificity and potency
23. How proteolysis drives the cell cycle
24. Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown
25. Subunit arrangement in the human 20S proteasome
26. Incorporation of major histocompatibility complex-encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-gamma
27. Proteasome inhibitors: Valuable new tools for cell biologists
28. Inhibitors of the chymotrypsin-like activity of proteasome based on di- and tri-peptidyl alpha-keto aldehydes (glyoxals)
29. Identification, purification, and characterization of a protein activator (PA28) of the 20S proteasome (macropain)
30. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: Development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone
31. Purification and characterization of a high molecular weight proteinase (macropain) from human erythrocytes
32. The high molecular weight multicatalytic proteinase, macropain, exists in a latent form in human erythrocytes
33. Eponemycin exerts its antitumor effect through inhibition of proteasome function
34. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity
35. The behavior and significance of slow-binding enzyme inhibitors
36. Differential effects of bovine PA28 on six peptidase activities of the lobster muscle proteasome (multicatalytic proteinase)
37. Regulation of the peptidylglutamyl-peptide hydrolyzing activity of the pituitary multicatalytic proteinase complex
38. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor
39. Lactacystin, a specific inhibitor of the proteasome, inhibits human platelet lysosomal cathepsin A-like enzyme
40. Vinyl sulfones as mechanism-based cysteine protease inhibitors
41. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
42. Evidence for the existence of a non-catalytic modifier site of peptide hydrolysis by the 20 S proteasome
43. Apoptosis induction resulting from proteasome inhibition
44. Eponemycin analogs: Synthesis and use as probes of angiogenesis
45. Total synthesis of the potent proteasome inhibitor epoxomicin: A useful tool for understanding proteasome biology
46. Inhibition of the proteolytic activity of the multicatalytic proteinase complex (proteasome) by substrate-related peptidyl aldehydes
47. Evidence that pituitary cation-sensitive neutral endopeptidase is a multicatalytic protease complex